Washington, DC – Today, members of the Obesity Action Coalition (OAC) will gather on Capitol Hill to meet with various legislators to express the importance of expanding access to obesity care and urge legislators to co-sponsor the Treat and Reduce Obesity Act (TROA). TROA is a bipartisan bill that will give Medicare-eligible Americans greater access
Read Article

TAMPA, Fla., Nov. 28, 2023 — The Obesity Action Coalition (OAC) announces the publication of a “Joint Statement in Support of Closing Gaps in the Drug Approval Process and Drug Labeling for People with Obesity.” The statement is co-signed by the OAC, The Obesity Society, the Stop Obesity Alliance, the Obesity Medicine Association, and the
Read Article

  On behalf of the American Society for Metabolic and Bariatric Surgery, the Obesity Action Coalition (OAC), the Obesity Medicine Association, the STOP Obesity Alliance, and The Obesity Society (TOS), we call on the FDA to close gaps in the testing and approval process for new drugs intended for use by people with obesity. Currently,
Read Article

  GivingTuesday is an international day of giving where people all over the world donate to charities they love. We love GivingTuesday because it showcases the incredible strength of our OAC Community – a powerful force working to create a world where everyone can access the care, understanding and support they need. Why GivingTuesday Matters:
Read Article

The New England Journal of Medicine recently published the results of the SELECT Study, giving valuable insights into the complex disease of obesity. The study shows Semaglutide can help prevent heart problems like cardiovascular deaths, strokes and heart attacks in people with obesity. In response, the country’s leading obesity expert organizations, the Obesity Action Coalition (OAC),
Read Article

The Obesity Action Coalition (OAC) is pleased to share that Carmot Therapeutics, Inc. has joined OAC’s Chairman’s Council at the Bronze level! Thank you for committing to support and champion the OAC’s mission. About Carmot Therapeutics, Inc.  Carmot Therapeutics is a clinical-stage biotechnology company dedicated to developing life-changing therapeutics for people living with metabolic diseases,
Read Article

Meet Mary Tripp, a long-time member of the Obesity Action Coalition (OAC) who stands out not only for her passion for advocacy but also for her creativity that lights up OAC Conventions. Mary’s journey with obesity started early, exposing her to challenges with weight and stigma since childhood. Through ups and downs, she found acceptance
Read Article

The Obesity Action Coalition (OAC) is pleased to share that Intellihealth has joined OAC’s Chairman’s Council at the Patron level! Thank you for committing to supporting and championing the OAC’s mission. About  Intellihealth Intellihealth is the leading software and clinical services company scaling and democratizing access to compassionate and comprehensive medical obesity treatment.  Founded by
Read Article

The Obesity Action Coalition (OAC) is pleased to share that KVK Tech has joined OAC’s Chairman’s Council at the Bronze level! Thank you for committing to support and champion the OAC’s mission. About  KVK Tech KVK Tech, Inc. is a pharmaceutical company that specializes in the development, manufacture and distribution of FDA-approved medications. Headquartered in
Read Article